Compare BLNK & BHST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BLNK | BHST |
|---|---|---|
| Founded | 2009 | 2007 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | |
| Sector | Consumer Discretionary | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 99.2M | 117.2M |
| IPO Year | N/A | N/A |
| Metric | BLNK | BHST |
|---|---|---|
| Price | $0.70 | $4.83 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 1 |
| Target Price | $2.13 | ★ $14.00 |
| AVG Volume (30 Days) | ★ 3.4M | 34.8K |
| Earning Date | 03-12-2026 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $106,631,000.00 | $32,720,000.00 |
| Revenue This Year | N/A | $116.40 |
| Revenue Next Year | $17.87 | $55.91 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 45.88 |
| 52 Week Low | $0.63 | $4.65 |
| 52 Week High | $2.65 | $12.80 |
| Indicator | BLNK | BHST |
|---|---|---|
| Relative Strength Index (RSI) | 39.95 | 43.67 |
| Support Level | $0.64 | $4.82 |
| Resistance Level | $0.72 | $5.42 |
| Average True Range (ATR) | 0.06 | 0.42 |
| MACD | -0.01 | 0.00 |
| Stochastic Oscillator | 21.10 | 14.67 |
Blink Charging Co is an owner, operator, and provider of electric vehicle (EV) charging services. The company offers both residential and commercial EV charging equipment, enabling EV drivers to easily recharge at various location types. The company's business is the sale and distribution of electric vehicle charging equipment and its associated revenues earned from customers and/or Property Partners who use equipment connected to its network. It earns a majority of revenue from U.S.A.
BioHarvest Sciences Inc is the developer and owner of the patented bio-cell growth platform farming technology. This company is the industrial large-scale plant cell growth technology capable of directly and constantly producing active plant ingredients without the necessity to grow the plant itself. The company is focused on leveraging its botanical synthesis technology to develop the next generation of science-based and clinical therapeutic solutions, within two business verticals - nutraceutical health and wellness products such as dietary supplements, and the development of plant cell-based Active Pharmaceutical Ingredients (APIs) that focus on specific medical indications.